The Insurance Amendment Bill, set to be introduced in Parliament's monsoon session, proposes raising the foreign direct ...

CuraTeQ Biologics s.r.o., announced that the CHMP of the European Medicines Agency has adopted a positive opinion recommending marketing authorisation of Dazublys®, its trastuzumab biosimilar, for the ...